In another study, the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) that included 1329 patients with chronic HF, it was observed that Gal3 values measured at baseline and those measured at 3 months of follow-up were related to increased mortality and rehospitalization for HF [7]. This evidence concerns the gene LGALS3 and hydrops fetalis.